Nanomedicinal Aspects in Cardiovascular Diseases
Pp. 6-16 (11)
Mohd. Aamir Mirza,
There is hardly any approved drug product for a cardiovascular ailment that
utilizes nanotechnology. Although there are a few products in this category, they do not
claim to be nano-therapeutics. An exhaustive evaluation of clinical trial databases
indicates that in the near future, we may see some drug products in the market in this
category. There are several similar investigational products by different groups across
the globe. A comprehensive collection of published literature augurs the inclination of
scientists in this field. The use of nanotechnology in cardiovascular is beneficial owing
to Critical Quality Attributes that can be imparted based on the size, spatial
arrangement of drug molecules, release profile, etc. In some cases, drug release
characteristics have to be in sync with circadian rhythm, which can be easily obtained
using this technology. The section of the book tries to highlight some of the aspects
related to the exploration of nanotechnology in the case of cardiovascular treatment.
Cardiac ischemia, CT, MRI, Nanomedicine, PET.